Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
C. Ann Merrifield currently holds 30,000 shares of Lyra Therapeutics, Inc. (LYRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, C. Ann Merrifield has been a net buyer of LYRA stock. They have purchased $292.7K and sold $0 worth of shares.
C. Ann Merrifield's most recent insider trade was on Jun 13, 2024, when they sold 30,000 shares at $0.00 per share.
C. Ann Merrifield serves as Executive at Lyra Therapeutics, Inc. (LYRA). They have executed 26 insider transactions totaling $292.7K over their tenure at the company.
C. Ann Merrifield holds the position of Executive at Lyra Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
C. Ann Merrifield has shown a buying trading pattern, with $292.7K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by C. Ann Merrifield was on Oct 1, 2007, when they sold $428.8K worth of PYX shares. This transaction involved 23,434 shares at $18.30 per share.
C. Ann Merrifield currently owns 30,000 shares of Lyra Therapeutics, Inc. (LYRA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of C. Ann Merrifield's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. C. Ann Merrifield has 26 Form 4 filings on record as an insider at Lyra Therapeutics, Inc..
Set alerts for C. Ann Merrifield and 40,000+ other insiders.